
PhaseV is a Boston-based technology company that leverages advanced causal machine learning and GenAI, augmented by an expansive data lake and real-world data (RWD), to empower biopharma sponsors and CROs with fast, accurate, and efficient clinical development decisions. The company offers a comprehensive suite of AI-powered solutions that optimize every phase of the clinical trial process, helping clients to rapidly design and implement adaptive and Bayesian clinical trials, analyze data for heterogeneous treatment effects, and improve trial planning. With over 30 biopharma and CRO customers and a commitment to transforming clinical development, PhaseV is positioned to bring new treatments to patients more efficiently.

PhaseV is a Boston-based technology company that leverages advanced causal machine learning and GenAI, augmented by an expansive data lake and real-world data (RWD), to empower biopharma sponsors and CROs with fast, accurate, and efficient clinical development decisions. The company offers a comprehensive suite of AI-powered solutions that optimize every phase of the clinical trial process, helping clients to rapidly design and implement adaptive and Bayesian clinical trials, analyze data for heterogeneous treatment effects, and improve trial planning. With over 30 biopharma and CRO customers and a commitment to transforming clinical development, PhaseV is positioned to bring new treatments to patients more efficiently.
Founded: 2023
Headquarters: Cambridge / Boston, MA
Sector: AI/ML for clinical trial optimization (biopharma/CRO)
Customers: 30–45+ biopharma and CRO customers (company claims)
Funding: Series A on 2025-05-13; total funding reported ~$65M
| Company |
|---|
Clinical trial design and operations optimization, subgroup/heterogeneous treatment effect analysis, adaptive and Bayesian trial implementation.
2023
Pharmaceutical Manufacturing
Seed round participation included Viola Ventures
Series A reported as led by Accel and Insight Partners
“Participation from Accel, Insight Partners, Exor Ventures, Viola Ventures, LionBird”
PhaseV is a Boston-based technology company that redefines clinical development at scale with its enterprise-ready, multi-modal AI/ML platform — accelerating decisions, de-risking trials, and driving more efficient portfolio strategies. With over $65M raised from Accel, Insight, and others, we are poised to make a significant impact on how drugs are developed and brought to market.
Our tools span the entire pharmaceutical development process, from early program and portfolio decision-making through execution on registrational trials. From our Trial Optimizer platform which designs smarter clinical trials, to our ClinOps module, which enhances site selection by integrating patient-level insights, our offerings provide sponsors and CROs with a flexible, scalable toolkit for optimizing every stage of clinical development. We’re already collaborating with over 40 biopharma partners, including 7 of the top pharmaceutical companies, as well as multiple CROs and biotechs, with many more in late stage discussions.
To apply to this job, please click here: https://job-boards.greenhouse.io/phasev/jobs/4092238009
The Role:
We are seeking a dynamic and experienced Alliance Manager in the US to lead our efforts in managing and expanding relationships with key clients. The Alliance Manager will play a critical role in defining engagement strategy, driving revenue growth, and ensuring client satisfaction, at assigned accounts.
Your Responsibilities:
Reporting to the Head of Alliance Management, this person will join the Alliance Management team and own strategy implementation at their assigned accounts.
Account Management & Growth:
Develop and execute strategies to drive expansion, up-sell, cross-sell opportunities, and
revenue growth within assigned accounts.
Business Development, and delivery teams to ensure that ongoing projects are successful and
new opportunities are identified.
scientific and business stakeholders
Strategic Planning:
Collaborate with the Head of Alliance Management and extended leadership team to build
company strategy and roadmap.
materials, and resources to implement these strategies effectively.
Internal Collaboration & Operational Excellence:
Work cross-functionally with product, project management, data science, customer success,
and marketing teams to ensure seamless execution of projects at assigned accounts
Track KPIs, including customer satisfaction, retention, and revenue growth.
Participate in externally-facing marketing, through attendance at conferences and events, solidifying PhaseV brand recognition within assigned accounts
Develop an in-depth knowledge of company offerings to identify business opportunities. Gain an excellent understanding of the target market and ideal champions within biotech and pharmaceutical organizations.
Qualifications:
Desired Skills:
What We Offer: